Anthelmintics are medications that destroy helminths. Flukes, roundworms, and tapeworms are helminth parasites that look like worms. Anthelmintics must be selectively harmful to the parasite rather than the host. Some work by interfering with metabolic processes that are essential to the parasite but not to the host. Other anthelmintics are poorly absorbed via the gut, exposing the parasite to significantly higher anthelmintic concentrations than the host. The parasite is then expelled or digested after starvation or paralysis.

 

An anthelmintic is a medication that is used to treat parasitic worm infestations in animals. This comprises both flat and round worms, such as flukes (trematodes) and tapeworms (cestodes). These medications block metabolic activities that are essential to the parasite but not to the host. The intestines do not well absorb some anthelmintics. As a result, the parasite is exposed to the medicine at a far higher concentration than the host body. Neuromuscular coordination, energy production, and microtubular integrity are all important in the worm's life cycle. Antihelmintic medications are usually taken orally because this is the most stable way of administration.

 

Data Bridge Market Research analyses that the anthelmintics market was valued at USD 2,846.90 million in 2021 and is expected to reach USD 5,435.60 million by 2029, registering a CAGR of 8.42% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

 

North America dominates the anthelmintics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the growing prevalence of prevalence of helminth infections and rising healthcare expenditure will further propel the market's growth rate in this region. Additionally, growing focus of major key players on novel technology will further propel the market's growth rate in this region.

 

Read Full Report Summary @ https://www.databridgemarketresearch.com/reports/global-anthelmintics-market

 

Asia-Pacific is expected to be the fastest growing region during the forecast period of 2022-2029 due to surging number of geriatric population in this region. Also, development of healthcare infrastructure and rising government initiatives will further propel the market's growth rate in this region.

 

Some of the major players operating in the anthelmintics market are:

 

F. Hoffmann-La Roche Ltd. (Switzerland)
Mylan N.V. (US)
Teva Pharmaceutical Industries Ltd. (Ireland)
Sanofi (France)
Pfizer Inc. (US)
GlaxoSmithKline plc (UK)
Novartis AG (Switzerland)
Bayer AG (Germany)
Merck & Co., Inc. (US)
Allergan (Ireland)
AstraZeneca (UK)
Johnson & Johnson Private Limited (US)
Cipla Inc. (US)
Amneal Pharmaceuticals LLC. (US)
Merck KGaA (Germany)
Mankind Pharma (India)
Zydus Cadila (India)
GALDERMA (Switzerland)
Zoetis (US)
Boehringer Ingelheim International GmbH. (Germany)
 

 

Related Reports:

 

 
 
 

 

About Data Bridge Market Research, Private Ltd

 

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

 

Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expands their reach by opening a new office in Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated Team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

 

Contact

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Corporatesales@databridgemarketresearch.com